Cargando…
Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient-Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma
Circulating tumor cells (CTCs) are cells shed from solid tumors into circulation and have been shown to be prognostic in the setting of metastatic disease. These cells are obtained through a routine blood draw and may serve as an easily accessible marker for monitoring treatment effectiveness. Becau...
Autores principales: | Torphy, Robert J., Tignanelli, Christopher J., Kamande, Joyce W., Moffitt, Richard A., Herrera Loeza, Silvia G., Soper, Steven A., Yeh, Jen Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929698/ https://www.ncbi.nlm.nih.gov/pubmed/24586805 http://dx.doi.org/10.1371/journal.pone.0089474 |
Ejemplares similares
-
De novo compartment deconvolution and weight estimation of tumor samples using DECODER
por: Peng, Xianlu Laura, et al.
Publicado: (2019) -
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
por: Moffitt, Richard A., et al.
Publicado: (2015) -
Measurement of Protein Kinase B Activity in Single Primary Human Pancreatic
Cancer Cells
por: Proctor, Angela, et al.
Publicado: (2014) -
Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer
por: Anderson, Marybeth, et al.
Publicado: (2016) -
Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts
por: Lipner, Matthew B., et al.
Publicado: (2016)